700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Editorial Open Access
Most cancer therapies are seldom effective by using single anticancer drug therapeutics based on multiple tumor genetic alterations and molecular abnormalities. Drug combinations are commonly practiced in clinics. Yet, anticancer drug combination utilities need to transform from empirical to science-guided enterprises. This editorial offers the background knowledge of drug combination therapies by mathematical enquiry.
Drug combination, Mathematics, Cytotoxic anticancer drugs, Cancer stem cell, Personalized cancer therapy, Anticancer Drug Combinations